|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kotake K, Honjo S, Sugihara K, Kato T,
Kodaira S, Takahashi T, Yasutomi M, Muto T and Koyama Y: Changes in
colorectal cancer during a 20-year period: An extended report from
the multi-institutional registry of large bowel cancer, Japan. Dis
Colon Rectum. 46 10 Suppl:S32–S43. 2003.PubMed/NCBI
|
|
3
|
Tamakoshi A, Nakamura K, Ukawa S, Okada E,
Hirata M, Nagai A, Matsuda K, Kamatani Y, Muto K, Kiyohara Y, et
al: Characteristics and prognosis of Japanese colorectal cancer
patients: The BioBank Japan Project. J Epidemiol. 27:S36–S42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shirota Y, Stoehlmacher J, Brabender J,
Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg
PV and Lenz HJ: ERCC1 and thymidylate synthase mRNA levels
predict survival for colorectal cancer patients receiving
combination oxaliplatin and fluorouracil chemotherapy. J Clin
Oncol. 19:4298–4304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crozier JEM, McKee RF, McArdle CS,
Angerson WJ, Anderson JH, Horgan PG and McMillan DC: The presence
of a systemic inflammatory response predicts poorer survival in
patients receiving adjuvant 5-FU chemotherapy following potentially
curative resection for colorectal cancer. Br J Cancer.
94:1833–1836. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogata Y, Matono K, Mizobe T, Ishibashi N,
Mori S, Akagi Y, Ikeda S, Ozasa H, Murakami H and Shirouzu K: The
expression of vascular endothelial growth factor determines the
efficacy of post-operative adjuvant chemotherapy using oral
fluoropyrimidines in stage II or III colorectal cancer. Oncol Rep.
15:1111–1116. 2006.PubMed/NCBI
|
|
7
|
Ogawa M, Watanabe M, Mitsuyama Y, Anan T,
Ohkuma M, Kobayashi T, Eto K and Yanaga K: Thymidine phosphorylase
mRNA expression may be a predictor of response to post-operative
adjuvant chemotherapy with S-1 in patients with stage III
colorectal cancer. Oncol Lett. 8:2463–2468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsuneoka M, Koda Y, Soejima M, Teye K and
Kimura H: A novel myc target gene, mina53, that is involved in cell
proliferation. J Biol Chem. 277:35450–35459. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teye K, Tsuneoka M, Arima N, Koda Y,
Nakamura Y, Ueta Y, Shirouzu K and Kimura H: Increased expression
of a Myc target gene Mina53 in human colon cancer. Am J Pathol.
164:205–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
West NP, Kobayashi H, Takahashi K,
Perrakis A, Weber K, Hohenberger W, Sugihara K and Quirke P:
Understanding optimal colonic cancer surgery: Comparison of
Japanese D3 resection and European complete mesocolic excision with
central vascular ligation. J Clin Oncol. 30:1763–1769. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stewart J, Evan G, Watson J and Sikora K:
Detection of the c-myc oncogene product in colonic polyps and
carcinomas. Br J Cancer. 53:1–6. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sikora K, Chan S, Evan G, Gabra H, Markham
N, Stewart J and Watson J: c-myc oncogene expression in colorectal
cancer. Cancer. 59:1289–1295. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y,
Kim CG, Cantor AB and Orkin SH: A Myc network accounts for
similarities between embryonic stem and cancer cell transcription
programs. Cell. 143:313–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133+ cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salcido CD, Larochelle A, Taylor BJ,
Dunbar CE and Varticovski L: Molecular characterisation of side
population cells with cancer stem cell-like characteristics in
small-cell lung cancer. Br J Cancer. 102:1636–1644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bora-Singhal N, Perumal D, Nguyen J and
Chellappan S: Gli1-mediated regulation of Sox2 facilitates
self-renewal of stem-like cells and confers resistance to EGFR
inhibitors in non-small cell lung cancer. Neoplasia. 17:538–551.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Xu W, Guo H, Zhang Y, He Y, Lee
SH, Song X, Li X, Guo Y, Zhao Y, et al: NOTCH1 signaling regulates
self-renewal and platinum chemoresistance of cancer stem-like cells
in human non-small cell lung cancer. Cancer Res. 77:3082–3091.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin HH, Chang YY, Lin JK, Jiang JK, Lin
CC, Lan YT, Yang SH, Wang HS, Chen WS, Lin TC and Chang SC: The
role of adjuvant chemotherapy in stage II colorectal cancer
patients. Int J Colorectal Dis. 29:1237–1243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roth AD, Tejpar S, Delorenzi M, Yan P,
Fiocca R, Klingbiel D, Dietrich D, Biesmans B, Bodoky G, Barone C,
et al: Prognostic role of KRAS and BRAF in stage II
and III resected colon cancer: Results of the translational study
on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol.
28:466–474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Resnick MB, Routhier J, Konkin T, Sabo E
and Pricolo VE: Epidermal growth factor receptor, c-MET,
beta-catenin, and p53 expression as prognostic indicators in stage
II colon cancer: A tissue microarray study. Clin Cancer.
10:3069–3075. 2004. View Article : Google Scholar
|
|
21
|
Ribic CM, Sargent DJ, Moore MJ, Thibodeau
SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R,
Shepherd LE, et al: Tumor microsatellite-instability status as a
predictor of benefit from fluorouracil-based adjuvant chemotherapy
for colon cancer. New Engl J Med. 349:247–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Davis AC, Wims M, Spotts GD, Hann SR and
Bradley A: A null c-myc mutation causes lethality before 10.5 days
of gestation in homozygotes and reduced fertility in heterozygous
female mice. Genes Dev. 7:671–682. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duesberg PH and Vogt PK: Avian acute
leukemia viruses MC29 and MH2 share specific RNA sequences:
Evidence for a second class of transforming genes. Proc Natl Acad
Sci USA. 76:1633–1637. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheiness D and Bishop JM: DNA and RNA from
uninfected vertebrate cells contain nucleotide sequences related to
the putative transforming gene of avian myelocytomatosis virus. J
Virol. 31:514–521. 1979.PubMed/NCBI
|
|
25
|
McKeown MR and Bradner JE: Therapeutic
strategies to inhibit MYC. Cold Spring Harb Perspect Med.
4:a0142662014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Whitfield JR, Beaulieu M-E and Soucek L:
Strategies to inhibit Myc and their clinical applicability. Front
Cell Dev Biol. 5:102017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen BJ, Wu YL, Tanaka Y and Zhang W:
Small molecules targeting c-Myc oncogene: Promising anti-cancer
therapeutics. Int J Biol Sci. 10:1084–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
